论文部分内容阅读
辅酶Q_(10)胶囊剂已由江苏省泰州生物化学制药厂研制成功.经江苏省人民医院等8家医院采用双盲法进行临床验证的结果表明:该制剂对冠心病、风湿性心肌炎、病毒性心肌炎等所致的室性早搏有较好的治疗效果,不仅可以明显改善患者的临床症状,而且能使其心电图迅速转为正常,有效率87.5％;作为免疫功能调整药用于慢性肝炎疗效达65％
Coenzyme Q_ (10) capsules have been successfully developed by Taizhou Biochemical Pharmaceutical Factory in Jiangsu Province.The results of double-blind clinical trial of 8 hospitals in Jiangsu Provincial People’s Hospital show that the preparation has good effects on coronary heart disease, rheumatic myocarditis, Ventricular premature beats caused by sexually transmitted myocarditis and so on have a good therapeutic effect, which can not only significantly improve the clinical symptoms of patients, but also make the electrocardiogram quickly turn to normal with an effective rate of 87.5%. As an immunomodulatory medicine for the treatment of chronic hepatitis Up to 65%